Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$100.11
+2.3%
$108.55
$81.20
$131.49
$23.89B1.39958,778 shs80,846 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,257.66
-0.2%
$1,260.42
$946.69
$1,521.01
$25.99B1.37168,282 shs4,171 shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$28.04
-0.5%
$26.62
$21.48
$32.91
$26.96B0.81959,203 shs35,482 shs
Signify Health, Inc. stock logo
SGFY
Signify Health
$30.49
$29.85
$10.70
$30.50
$7.21B0.372.48 million shsN/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
+1.18%-4.66%-13.78%-6.75%-20.68%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
+0.33%-3.97%-4.06%+9.67%-8.74%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-0.25%+0.99%+2.48%+27.39%-8.43%
Signify Health, Inc. stock logo
SGFY
Signify Health
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$100.11
+2.3%
$108.55
$81.20
$131.49
$23.89B1.39958,778 shs80,846 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,257.66
-0.2%
$1,260.42
$946.69
$1,521.01
$25.99B1.37168,282 shs4,171 shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$28.04
-0.5%
$26.62
$21.48
$32.91
$26.96B0.81959,203 shs35,482 shs
Signify Health, Inc. stock logo
SGFY
Signify Health
$30.49
$29.85
$10.70
$30.50
$7.21B0.372.48 million shsN/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
+1.18%-4.66%-13.78%-6.75%-20.68%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
+0.33%-3.97%-4.06%+9.67%-8.74%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-0.25%+0.99%+2.48%+27.39%-8.43%
Signify Health, Inc. stock logo
SGFY
Signify Health
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
2.76
Moderate Buy$135.8035.65% Upside
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
2.50
Moderate Buy$1,311.114.25% Upside
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
3.00
BuyN/AN/A
Signify Health, Inc. stock logo
SGFY
Signify Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SGFY, PHG, MTD, and BNTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/8/2025
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$136.00
8/21/2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$1,400.00 ➝ $1,600.00
8/14/2025
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$138.00 ➝ $136.00
8/5/2025
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$126.00 ➝ $134.00
8/5/2025
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$170.00 ➝ $150.00
8/4/2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$1,280.00 ➝ $1,275.00
8/4/2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$1,210.00 ➝ $1,230.00
7/28/2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$1,139.00 ➝ $1,210.00
7/16/2025
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$127.00 ➝ $126.00
7/10/2025
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$132.00 ➝ $133.00
7/8/2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$1,200.00 ➝ $1,280.00
(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$2.88B8.36N/AN/A$87.61 per share1.14
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$3.87B6.69$47.73 per share26.35($6.07) per share-207.19
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$19.50B1.38$3.08 per share9.11$13.86 per share2.02
Signify Health, Inc. stock logo
SGFY
Signify Health
$805.50M8.95$0.58 per share52.27$3.47 per share8.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
-$719.92M-$1.60N/AN/AN/A-12.20%-1.84%-1.59%11/3/2025 (Estimated)
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$863.14M$39.4931.9526.453.7821.46%-476.07%26.05%11/6/2025 (Estimated)
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-$758.55M$0.19147.3614.530.761.00%11.95%4.94%10/27/2025 (Estimated)
Signify Health, Inc. stock logo
SGFY
Signify Health
-$576.80M-$3.29N/AN/AN/A-75.40%-10.24%-5.86%N/A

Latest SGFY, PHG, MTD, and BNTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
-$1.41-$1.60-$0.19-$1.82$161.26 million$306.46 million
7/31/2025Q2 2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$9.58$10.09+$0.51$9.76$957.41 million$983.22 million
7/29/2025Q2 2025
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.2907$0.41+$0.1193$0.28$4.35 billion$5.05 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
N/AN/AN/AN/AN/A
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
N/AN/AN/AN/AN/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.822.91%N/A431.58%N/A
Signify Health, Inc. stock logo
SGFY
Signify Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
0.01
8.61
8.48
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
N/A
1.12
0.77
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.69
1.26
0.81
Signify Health, Inc. stock logo
SGFY
Signify Health
0.41
1.62
1.62

Institutional Ownership

CompanyInstitutional Ownership
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
15.52%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
95.07%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
13.67%
Signify Health, Inc. stock logo
SGFY
Signify Health
89.99%

Insider Ownership

CompanyInsider Ownership
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
19.20%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
0.77%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
N/A
Signify Health, Inc. stock logo
SGFY
Signify Health
8.02%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6,772240.40 million194.24 millionOptionable
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
17,30020.60 million20.44 millionOptionable
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
66,678962.92 millionN/AOptionable
Signify Health, Inc. stock logo
SGFY
Signify Health
2,200236.51 million217.54 millionOptionable

Recent News About These Companies

Simplify & Take Control Of Your Health
Signify Offsets Pressure In CVS’ Health Care Delivery Segment
How CVS' Signify is working with Oak Street to grow in-home care
TV20 Showcase: Health Management Tips from Signify Health
Signify Health | Morning Blend
Dignity Health appoints new head of Mercy General Hospital
Global Beta Rising Stars ETF (GBGR)

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioNTech stock logo

BioNTech NASDAQ:BNTX

$100.11 +2.23 (+2.28%)
As of 10:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.

Mettler-Toledo International stock logo

Mettler-Toledo International NYSE:MTD

$1,257.66 -2.47 (-0.20%)
As of 10:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Koninklijke Philips stock logo

Koninklijke Philips NYSE:PHG

$28.04 -0.13 (-0.47%)
As of 10:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Signify Health stock logo

Signify Health NYSE:SGFY

Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.